PRN Europe Health

Cision's/PR Newswire sharing #health and #wellness news. May include sponsored tweets.

[PRN Europe Health @PRNEHealth]

ICYMI: PR Newswire has rolled out a free, fully customizable #healthcare focused newsfeed. The newsfeed will feature releases on your site, not redirect traffic. Learn more here: https://t.co/vSJ8VRfiWE #health #content

[PRN Europe Health @PRNEHealth]

Zydus announces agreement with CVS Caremark to add Zituvio™, Zituvimet™ and Zituvimet™ XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) to its template formulary https://t.co/AalToBbu28

[PRN Europe Health @PRNEHealth]

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment https://t.co/56iRlvjnK5

[PRN Europe Health @PRNEHealth]

$RDHL awarded $8 million plus costs in New York Supreme Court summary judgment against Kukbo. #RDHL https://t.co/3XeUqKyAGH

[PRN Europe Health @PRNEHealth]

Meril Champions Innovation with Myval Octapro THV Launch at GISE 2024 & PCR LondonValves 2024 https://t.co/cdHcsdOnzW

[PRN Europe Health @PRNEHealth]

New Ipsos global survey shines a light on the myopia epidemic https://t.co/JpwWe05xN7

[PRN Europe Health @PRNEHealth]

#RDHL & @DukeMedSchool to develop #opaganib as a medical #countermeasure for phosgene injury, aimed toward advanced U.S. government-sponsored #FDA Animal Rule development. $RDHL PR: https://t.co/1EEA3pGhcj

[PRN Europe Health @PRNEHealth]

Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries https://t.co/Vspv2gJVao

[PRN Europe Health @PRNEHealth]

#RDHL #opaganib granted new @USPTO patent for identification of a novel biomarker of coronavirus pneumonia - prognostic for potential opaganib efficacy in treating COVID-19, valid through 2041. $RDHL PR: https://t.co/3vIehG2aUs

[PRN Europe Health @PRNEHealth]

Zydus announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable, contrast agents in the US https://t.co/49HR1qk9Rq

[PRN Europe Health @PRNEHealth]

#RDHL’s #Talicia, positioned first-line for the treatment of # HPylori infection in the new @AmCollegeGastro clinical guideline. Read the $RDHL PR: https://t.co/8LKcT43rTl

[PRN Europe Health @PRNEHealth]

Exciting Developments in Clinical Research: Axcellant's Groundbreaking Global Study https://t.co/brnaD2p9Ko

[PRN Europe Health @PRNEHealth]

#RDHL #opaganib granted @US_FDA #orphandrug status for #neuroblastoma, the most common #infant #malignancy accounting for 15% of #pediatric #cancer deaths. Broad #oncology potential & 7-years exclusivity. $RDHL PR: https://t.co/RDajPi1Y7o #FDA

[PRN Europe Health @PRNEHealth]

New publication in @antibioticsmdpi of ground-breaking positive data from #RDHL’s Phase 3 Crohn’s study shows #RHB-104 + standard of care (SoC) was 64% more effective than SoC alone. Primary endpoint met with high statistical significance $RDHL PR: https://t.co/CeUo4J8zAC

[PRN Europe Health @PRNEHealth]

YewMaker - New Playbook Launches to Tackle Global Challenge of Wasted Medicines https://t.co/zIuld6H0Bl

[PRN Europe Health @PRNEHealth]

@conceptmedicals ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US https://t.co/V7GZjrSQy1

[PRN Europe Health @PRNEHealth]

$RDHL 2023 results: “RedHill is transformed - focused on predominantly U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a disciplined cost-base & unburdened by debt, with a clear value proposition”. #RDHL PR: https://t.co/oJhncRRC01

[PRN Europe Health @PRNEHealth]

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price https://t.co/qCboCAca9C

[PRN Europe Health @PRNEHealth]

RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 https://t.co/cLIYmqPa86

[PRN Europe Health @PRNEHealth]

Response Plus Medical announces strategic acquisition of UK-based Prometheus as part of global expansion plans https://t.co/nliVRw7B64

[PRN Europe Health @PRNEHealth]

Oxford Medical Simulation Raises $12.6 Million in Series A Funding to Address Critical Healthcare Training Gap with Virtual Reality https://t.co/zidLCAUDXl